Ocular PD LLC


Ocular PD LLC has an exclusive license to develop and sell devices using patented Far-UV Sterilray™ Technology to the Ophthalmology sector.
• Ocular PhotoDisinfection LLC is an early-stage disinfection device manufacturer in Dover NH.

• Ocular PD is licensed to sell devices based on patented Far-UV Sterilray™ Technology exclusively to the Ophthalmology Sector from the holder of the patents SEdward Neister-Pathogen Path Consultants LLC.

• The Company is seeking to commercialize its first ocular device. • It has 3 commercialized disinfection devices now for sale.

Ocular PhotoDisinfection LLC is actively seeking to collaborate on development and commercialization of final devices for use in disinfecting corneas and eye-related surfaces for transplant, surgery, office treatments, and other ophthalmology applications, as well as other disinfection devices. The U.S. addressable market under any scenario is huge for ophthalmic disinfection devices. Other opportunities for sales include world markets and animal cornea replacements.

Unlike the standard UV wavelength, UV-C at 254nm, Far-UV Sterilray™ operates at 222nm, and its effect on pathogens is very different than UV-C. These tests have shown that the Far-UV Sterilray™ wavelength does not injure skin or cornea/endothelial cells while being applied for up to 20 seconds in duration. Other tests by independent researchers have demonstrated that Far-UV Sterilray™ kills all of the most egregious pathogens affecting donor corneal transplant surgeries in 2 seconds or less and the Candida spore in 20 seconds. Additional tests at Harvard University and Massachusetts General Hospital have demonstrated that there are no subsequent damaging effects on mammalian cells after application of Far-UV Sterilray™.

All patents are currently owned by S. Edward Neister, Pathogen Path Consultants LLC (PPC) and as the sole inventor, Neister has granted to Ocular PhotoDisinfection LLC a royalty-free license to make, use, sell, offer to sell, develop, and improve on, any of the technologies contained within such patents. PPC is filing additional patents on Far-UV Sterilray™ device variations.